The company aims to provide consulting services in the fields of pharmaceutical research and clinical development, particularly in medicinal chemistry, preclinical imaging agents, drug optimization, as well as global clinical development strategies, clinical development planning, study design, interaction with regulatory authorities, and translational medicine. The company may establish branches and subsidiaries both domestically and abroad, and may participate in other companies both domestically and abroad, as well as conduct all business that is directly or indirectly related to its purpose. The company may acquire, encumber, dispose of, and manage real estate both domestically and abroad. It may also undertake financing for its own or third-party account, as well as provide guarantees and sureties for subsidiaries and third parties.